Finley Financial LLC Invests $90,000 in iShares Biotechnology ETF (NASDAQ:IBB)

Finley Financial LLC bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 675 shares of the financial services provider’s stock, valued at approximately $90,000.

A number of other large investors have also recently made changes to their positions in IBB. BNP Paribas Financial Markets increased its holdings in shares of iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after buying an additional 538,899 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after purchasing an additional 164,000 shares during the last quarter. Aprio Wealth Management LLC bought a new position in iShares Biotechnology ETF during the 4th quarter valued at about $18,476,000. Aristides Capital LLC bought a new position in iShares Biotechnology ETF during the 2nd quarter valued at about $9,180,000. Finally, Sanctuary Advisors LLC bought a new position in iShares Biotechnology ETF during the 2nd quarter valued at about $8,118,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 2.6 %

Shares of NASDAQ:IBB opened at $136.10 on Wednesday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The firm’s 50-day moving average is $136.15 and its 200 day moving average is $141.84.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.